Healthcare; Private Equity; Regulatory Affairs · medium ·
Private equity's healthcare pivot creates a regulatory bottleneck
Private equity is shifting healthcare investment towards regulated assets like radiopharmaceuticals and specialised diagnostics, moving away from software. This strategy demands deep regulatory expertise, creating a bottleneck for firms lacking specialised compliance and M&A integration capabilities.
Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.